We have identified and extensively charac-
Type IV collagen, the major component of basement membranes, consists primarily of al(IV) and a2(IV) chains (1) . The complete primary structure of the al(IV) and a2(IV) chains from man (2, 3) and mouse (4, 5) and an a(IV) chain of Drosophila (6) have been reported. All these chains contain a highly conserved carboxyl-terminal noncollagenous domain (NC domain) of 227-231 residues and a collagenous domain of 1398-1456 residues. Unlike fibrillar collagens, the type IV collagen a chains contain numerous interruptions in the otherwise continuous Gly-Xaa-Yaa repeat sequence. The existence of two distinct type IV collagen a3(IV) and a4(IV) chains has also been reported (7, 8) , which indicates that this protein must have several molecular compositions. Immunological studies indicate that the major form of collagen IV containing the al(IV) and a2(IV) chains is a ubiquitous basement membrane component (see ref. 1 ). However, this may not always be the case, as the presence of other type IV collagen a chains in these antigens has not been ruled out. Evidence for region specificity, at least in the kidney, has been obtained with antibodies against the putative a3(IV) chain (9) .
Diseases, such as the Goodpasture syndrome and the Alport syndrome, that seem to be associated with type IV collagen defects provide models for studies of the minor chains. The Goodpasture antigen has been proposed to be the a3(IV) NC domain (9) . The Alport syndrome is an X chro-mosome-linked disease primarily characterized by hematuria and patchy splitting of the glomerular basement membrane (GBM) (10) (11) (12) . There is evidence that, at least in certain kindreds, the pathological mechanism is an alteration or even the complete absence of a type IV collagen-like a chain (13, 14) . However, the defect in the Alport syndrome cannot be in the al(IV) or a2(IV) genes since they have been mapped to 13qter (15, 16) .
MATERIALS AND METHODS
Isolation and Characterization of cDNA Clones. A human placenta cDNA library in Agtll (Clontech) was screened (3) using an oligonucleotide mixture TG(TC)CA(AG)GT(ACG-T)TG(TC)ATG (32 permutations) that codes for a type IV collagen NC domain consensus sequence Cys-Gln-Val-Cys-Met. The filters were rehybridized with cDNA clones HT-21 (17) and HD-4 (18) , which code for the human al(IV) and a2(IV) chains, respectively. Clones that were positive for the oligonucleotide mixture but not for the al(IV) and a2(IV) cDNAs were isolated, subcloned into M13 (19) vector, and sequenced (20) for initial characterization. For Nothern blot analysis (21) , total RNA was isolated from frozen tissues using an acid guanidinium thiocyanate/phenol/chloroform extraction procedure (22) .
Synthetic Peptides and Preparation of Antibodies to an a5(IV)-Derived Peptide. An a5(IV) peptide Ser-Asp-Met-Phe-Ser-Lys-Pro-Gln-Ser-Glu and an al(IV) peptide Ser-Glu-Met-Phe-Lys-Lys-Pro-Thr-Pro-Ser were made. For the preparation of antiserum, the a5(IV) peptide was coupled to ovalbumin (23) and a rabbit was immunized.
Immunological Methods. For blotting, normal human skin fibroblasts were extracted with SDS buffer and electrophoresed under reducing conditions (24) . The separated proteins were transferred to a nitrocellulose filter for immunostaining. Immunohistological staining was carried out on 4-,um-thick methanol-fixed cryosections from an adult human kidney obtained at autopsy. Fluorescein isothiocyanate-(Janssen Biochimica) or peroxidase-(Zymed Laboratories) conjugated anti-rabbit IgG was used for immunostaining. Peroxidase activity was visualized using 4-chloro-1-naphthol (25) and H202 as substrates.
Chromosomal Assignment. Chromosomal assignment of the human a5(IV) gene was carried out using a panel consisting of 36 human-mouse hybrids derived from 14 unrelated human cell lines and 4 mouse cell lines (26, 27) . Southern blot analysis was performed with 10 ,g of HindIII-digested DNA from each cell line by using 32P-labeled MD-6 cDNA as probe Abbreviations: NC, noncollagenous; GBM, glomerular basement membrane.
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RESULTS
Isolation of cDNA Clones Coding for a5(IV), Type IV Collagen a Chain. The strategy for the isolation of cDNA clones coding for potential type IV collagen a chains was to make use of the fact that there are short identical amino acid sequences in the carboxyl-terminal NC domain of the human and mouse al(IV) and a2(IV) chains (17, 18, 31, 32) as well as in the evolutionarily distant Drosophila a(IV) chain (6) . It was concluded that these sequences are essential for the structure or function of the protein, and they could, therefore, be expected to be present in all other potential a chains of type IV collagen. One such sequence is Cys-Gln-Val-Cys-Met. A 15-mer synthetic oligonucleotide coding for this sequence was used as probe for screening of the cDNA library.
Primary screening of 360,000 plaque-forming units yielded 720 duplicate positive signals. Since it could be anticipated that a large portion of the signals were derived from al(IV) and a2(IV) cDNA clones, the clones HT-21 (17) and HD-4 (18) coding for these chains, respectively, were used to rescreen the same filters under stringent hybridization and washing conditions (21) . This resulted in eight negative clones that were subcloned into M13 vectors and sequenced from both ends for initial characterization. Six of those coded for a unique type IV collagen-like a chain. The longest clone, MD-6 [1.4 kilobases (kb)], encoded a short part of a 3' untranslated region, a complete NC domain, and a part of the collagenous domain ( Fig. 1) .
The MD-6 clone was then used to rescreen the same cDNA library and this yielded, among others, one 2.0-kb clone (PL-31) that reached 955 base pairs (bp) further upstream and two clones of 2.4 kb (PC-4) and 1.8 kb (PL-35) that coded for the 3' untranslated region, the NC domain, and a part of the collagenous domain ( Fig. 1 ).
Nucleotide and Amino Acid Sequence of the Human a5(IV)
Chain. The complete nucleotide sequencer ofthe overlapping clones for the type IV a chain we have termed a5(IV) revealed a 2316-bp open reading frame coding for 772 amino acid residues and a 1201-bp 3' untranslated region (Fig. 2) . The PC-4 cDNA clone has 1167 bp of a 3' untranslated region sequence and a 22-nucleotide poly(A) tail that is preceded by two potential polyadenylylation signals, AATTAAA or AATATA (33), instead of the typical AATAAA consensus sequence (Fig. 2 ). The PL-35 cDNA clone that has no poly(A) tail reaches 34 nucleotides further downstream of PC-4, indicating that at least two sizes of mature mRNAs exist. The cDNA-deduced amino acid sequence contains 543 residues of a collagenous Gly-Xaa-Yaa repeat sequence that has five imperfections of 2-5 residues and a 229-residue carboxyl-terminal NC domain. The NC domain contains 12 cysteine residues. The conserved Cys-Gln-Val-Cys-Met sequence was located at the same site as in the other known type IV collagen a chains ( Fig. 2) . Northern blot analysis with total RNA from human embryonic kidney and lung demonstrated that the gene codes for a transcript(s) of about 6.5 kb and the signal is about three times more intense with RNA from kidney than from lung ( Fig. 3 ). Using kidney total RNA, the ratio of the bands was about 40:20:1, respectively, with al(IV), a2(IV), and a5(IV) cDNA probes of similar size and specific activity (data not shown). Therefore, the a5(IV) chain is a minor basement membrane component in whole kidney. (Fig. 2 ). All the chains are remarkably similar but the a5(IV) chain is more closely related to the a 1(IV) chain than to the a2(IV) chain. In the NC domain the sequence identity between the a5(IV) chain and a 1(IV) is 83% whereas it is 63% with the a2(IV) chain. The NC domain of the a5(IV) and al(IV) chains has 229 residues whereas it is 227 residues in the a2(IV) chain. The sequence available from the collagenous domain of the a5(IV) chain is 58% identical with the corresponding region of the al(IV) chain but only 46% identical with that of the a2(IV) chain. All the interruptions in the collagenous domain match in their location between the al(IV) chain and the a5(IV) chain (Fig. 2) .
Short sequences around the presumable junction between the collagenous domain and the NC domain of the putative bovine a3(IV) and a4(IV) chains have been reported (7, 8) .
Comparison of those with the corresponding region of the a5(IV) chain shows sequence identity with the a3(IV) of only 46%, when the figure for the putative a4(IV) chain is only 24%. This extensive difference cannot be explained by interspecies differences because, for example, the human and murine al(IV) chains have complete sequence homology in this region (4, 17) . We, therefore, conclude that the cDNA clones described here code for a5(IV), a distinct chain of the type IV collagen a chain family.
Immunoblot Analysis and Indirect Immunofluorescence with Antisera Against an a5(IV) Chain-Derived Peptide. Total protein from cultured human fibroblasts was used for immunoblot analysis. Filter strips containing the blotted protein were incubated with the antibodies made against the a5(IV)chain-derived peptide. The antiserum stained a band of the same size as the a 1(IV) chain (Fig. 4, lane B) . This stain was blocked by preincubation of the antiserum with the antigen (Fig. 4 , lane C). The stain was not blocked by preincubation of the antiserum with a corresponding al(IV) peptide conjugate (Fig. 4 , lane D). Preimmune serum was completely negative (Fig. 4, lane A) . Nonspecific stain of a band about the size of the a2(IV) chain and of lower molecular weight could be seen in all samples (lanes A-D). In lane B some possible degradation products are also visible.
Immunofluorescence studies on cryosections from a human adult kidney with the a5(IV) peptide antiserum gave a reaction that was highly restricted to the GBM whereas the basement membrane of the Bowman's capsule was completely negative (Fig. SA) . Furthermore, little if any reaction was seen in the tubular or vascular basement membranes. No reaction was obtained with the preimmune serum (data not shown). In contrast, antiserum prepared against the NC domain of type IV collagen isolated from human placenta showed a strong stain of the basement membranes of Bowman's capsule and tubuli as well as the GBM (Fig. SB) .
MThe sequence reported in this paper has been deposited in the GenBank data base (accession no. M31115). Proc. Natl. Acad. Sci. USA 87 (1990) G R S G V P G L K G D D G L Q G Q P G L P G P T G E K G S K G E P G L P G P P G P MID P N L LIG S autosome translocations with various lengths of the X chromosome further localized COLAAS to the Xq22-26 region (cell hybrid data not presented, but are available from author). In situ hybridization confirmed the localization of COLA5 to chromosome Xq22 (Fig. 6) . No other chromosome had counts above background.
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DISCUSSION
The present work demonstrates the existence of a previously unknown polypeptide chain of basement membrane (type IV) collagen. The amino acid sequence derived from the cDNA clones isolated in this study provided about 50% of the entire amino acid sequence from the carboxyl-terminal end of this chain, which we refer to as a5(IV). The a5(IV) chain is more closely related to the al(IV) chain than to the a2(IV) chain. This is evident from the exactly same size and high sequence identity of the NC domains and also because the locations of all imperfections in the helical domain are conserved. To date, there are only minor protein and sequence data available from the potential a3(IV) and a4(IV) chains (7, 8) . It is evident from the present study that the sequence of the a5(IV) chain is distinct from the sequences of those chains.
Antiserum to a 10-residue synthetic peptide with a sequence from the NC domain was made. The peptide antigen had a 50% sequence identity with the sequence from the al(IV) chain, which was the lowest possible sequence identity for a 10-peptide sequence. Immunoblot analysis against total protein from human fibroblasts showed that the a5(IV) antiserum stained a band of the same size as the a 1(IV) chain (185 kDa). Since the stain could be blocked by preincubation of the antiserum with the a5(IV)-peptide-ovalbumin antigen but not by preincubation with the a l(IV)-peptide-ovalbumin conjugate we conclude that the antiserum does not detect a 1(IV).
Interestingly, immunostaining of kidney was restricted to the GBM, indicating a highly tissue-specific distribution of the a5(IV) chain. There was no apparent stain in the tubular basement membranes or in the Bowman's capsule. Antibodies against the putative NC domain of the a3(IV) and a4(IV) chains have shown strong reaction in the GBM and in the Bowman's capsule (9) . Reactivity of our a5(IV) chain antibodies with these chains cannot be ruled out. The antiserum against human placenta type IV collagen stained the GBM, Bowman's capsule and tubular basement membranes. The placental antigen consists presumably mainly of a 1(IV) and a2(IV) chains but the presence of other type IV collagen chains cannot be excluded. Accordingly, the al(IV) and
We thank Juha and Leila Risteli for generously providing antibodies against human type IV collagen and Helena Autio-Harmainen for providing the human kidney tissues. This work was supported in part by grants from the National Research Council for Natural Sciences, Academy of Finland, The Juselius Foundation, and the National Institutes of Health (GM20454 and HD05196). 13 FIG. 6 a2(IV) chains might also have various distributions in different basement membranes of the body. To date there are no immunohistological data on the tissue specificity of a1(IV) and a2(IV). Thus type IV collagen appears to be a considerably more complex protein than previously thought with various chain compositions, tissue specificity, and functions. The results of this study establish that the human a5(IV) chain gene (COL4AS) is on chromosome X at band q22, which is particularly intriguing with respect to the Alport syndrome. This disease has four X chromosome-linked phenotypes of which at least two have been mapped to Xq22-24 in three studies (10, 12). As described above, the GBM is structurally defective and some evidence suggests that there is an alteration or even complete absence of a type IV collagen-like a chain (13) . Kashtan et al. (14) have reported that an Alport (X chromosome-linked) patient who obtained a renal allograft developed antibodies against a 26-kDa NC domain-like component. This is the same size as that of the NC domain of the a l(IV) chain (14) . It is obvious that the chain possibly missing in Alport patients is not al(IV) since its gene has been localized to 13q. Consequently, the 26-kDa component detected by the Alport antiserum could be the NC domain of a5(IV), as it has almost exactly the same size as that of the al(IV) chain. Current data strongly suggest that one or even more type IV collagen a chains are defective in the GBM of certain patients with X chromosome-linked Alport syndrome. This could be due to a mutation involving gene(s) coding for type IV collagen a chain(s), but no type IV collagen gene has previously been assigned to this chromosome. Since COL4AS is located in the locus of the Alport syndrome, it is quite possible that it is involved in the generation of one type of the X chromosome-linked disease. However, Southern blot analysis on DNA from one male patient with X chromosome-linked Alport syndrome did not reveal an abnormal pattern with several restriction enzymes (data not shown), indicating no major rearrangement-e.g., a deletion in the 3' end of the gene. There might also be another type IV collagen a chain on this locus in analogy with the genes for the human al(IV) and a2(IV) chains on 13q (34) . The definite answer about the involvement of the a 5(IV) locus or another possibly closely linked locus for a type IV collagen a chain in Alport syndrome, therefore, requires further detailed studies on the entire a5(IV) gene locus in both normal individuals and Alport patients.
